NEW YORK (GenomeWeb) – Meridian Bioscience today reported a 7 percent year-over-year uptick in fiscal first quarter revenues driven by balanced contributions from its key operating segments.

For the three months ended Dec. 31, the Cincinnati-based molecular diagnostics and life science research tools firm brought in revenue of $48 million compared to $44.8 million in the same quarter last year and beating the consensus analysts' estimate of $46.2 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The partially reinstated US travel ban leaves space for uncertainty for researchers, Nature News says.

Researchers find a number of traits differ by sex and could affect mouse model studies, according to Reuters.

Tweaking the skin microbiome could help address some skin conditions, the New York Times reports.

In PNAS this week: DNA methylation profiles of tumor tissue, gene dynamics in prokaryotes, and more.